Azithromycin and Odefsey drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azithromycin (azithromycin) and Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate). Common drug interactions include arthralgia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Azithromycin and Odefsey. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

What is Odefsey?

Odefsey has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 4,605 Odefsey users. Check the latest studies of Odefsey.



On Jul, 26, 2026

45 people who take Azithromycin and Odefsey together, and have interactions are studied.

Azithromycin and Odefsey drug interactions.

What are the common drug interactions of Azithromycin and Odefsey, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Blood creatinine increased
  3. Bone loss
  4. Chronic kidney disease
  5. Death
  6. Depressed mood
  7. Dysstasia (difficulty in standing)
  8. Epicondylitis (tennis elbow)
  9. Exercise tolerance decreased
  10. Mobility decreased (ability to move is reduced)

male:

  1. Pain
  2. Emotional distress
  3. Wrist fracture
  4. Depression
  5. Fatigue (feeling of tiredness)
  6. Hypertension (high blood pressure)
  7. Multiple fractures
  8. Tooth loss
  9. Blood creatinine increased
  10. Mobility decreased (ability to move is reduced)

What are the common drug interactions of Azithromycin and Odefsey, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Glomerulosclerosis (a hardening of the glomerulus in the kidney)
  6. Hypertension (high blood pressure)
  7. Immune system disorder
  8. Mobility decreased (ability to move is reduced)
  9. Pain
  10. Renal impairment (severely reduced kidney function)

30-39:

  1. Renal failure (kidney dysfunction)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Mobility decreased (ability to move is reduced)
  8. Renal cyst (kidney cyst)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

40-49:

  1. Wrist fracture
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Multiple fractures
  4. Renal tubular disorder (disease of kidney tubules)
  5. Rib fracture
  6. Ankle fracture
  7. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  8. Arteriovenous malformation
  9. Back pain
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

50-59:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Osteoporosis (bones weak and more likely to break)
  6. Chronic kidney disease
  7. Renal impairment (severely reduced kidney function)
  8. Bone density decreased
  9. Depression
  10. Exercise tolerance decreased

60+:

  1. Emotional distress
  2. Pain
  3. Multiple fractures
  4. Anaemia (lack of blood)
  5. Asthenia (weakness)
  6. Depression
  7. Erectile dysfunction
  8. Fall
  9. Femur fracture
  10. Fracture pain

What are the existing conditions these people have? *

  1. Hypersensitivity: 5 people, 11.11%
  2. Pain: 4 people, 8.89%
  3. Infection: 4 people, 8.89%
  4. Depression: 4 people, 8.89%
  5. Bacterial Infection: 4 people, 8.89%
  6. Nausea And Vomiting: 3 people, 6.67%
  7. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 6.67%
  8. Herpes Zoster: 3 people, 6.67%
  9. Cough: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Azithromycin and Odefsey?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azithromycin and Odefsey:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Odefsey:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Odefsey and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on azithromycin and emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate (the active ingredients of Azithromycin and Odefsey, respectively), and Azithromycin and Odefsey (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: